Creative Medical Technology Holdings, Inc. Operating Lease, Right-of-Use Asset, Amortization Expense
Creative Medical Technology Holdings, Inc. (CELZ) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $22.97 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2023-08-11
- 2023-06-30: Operating Lease, Right-of-Use Asset, Amortization Expense 6 month $22.97K.
- 2022-06-30: Operating Lease, Right-of-Use Asset, Amortization Expense 6 month $22.97K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month |
|---|---|
| 2023-06-30 | $22.97K 10-Q · filed 2023-08-11 |
| 2022-06-30 | $22.97K 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |